Jaquelina Sonoe Ota Arakaki

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 151 citations

Hypertension, Pulmonary Arterial Hypertension, Phosphodiesterase-5 Inhibitors +11

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

R. James White, Carlos Jerjes‐Sánchez, G. Meyer et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 142 citations · Full text

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry

Stefan Guth, Andrea Maria D’Armini, Marion Delcroix et al. · ERJ Open Research · 2021 · 128 citations · Full text

Heart rate recovery in pulmonary arterial hypertension: Relationship with exercise capacity and prognosis

Roberta Pulcheri Ramos, Jaquelina Sonoe Ota Arakaki, Priscila Barbosa et al. · American Heart Journal · 2012 · 90 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +12

Subacute and chronic hypersensitivity pneumonitis: Histopathological patterns and survival

Mariana Silva Lima, Ester Nei Aparecida Martins Coletta, Rimarcs Gomes Ferreira et al. · Respiratory Medicine · 2009 · 89 citations · Full text

Inflammation, Autoimmune Disease, Allergy +8